Latest filing published 26 Feb 2020 for IRLAB Therapeutics AB, €8,945.
Filing timeline
BuySaleInsider track record
No signal scores available.
Closed purchases
Not enough history yet: 0 closed purchases, at least 2 are needed.
Purchases by company
Cecilia Tivert Stenberg: trading record in brief
Cecilia Tivert Stenberg discloses dealings in IRLAB Therapeutics AB to Finansinspektionen. The record holds 5 filings, for trades running from 24 February 2017 to 25 February 2020.
The open-market side counts 1 purchase for €8,945 alongside 1 sale for €64k. Taken together, the sales exceed the purchases by €55k. Unlike grants, an open-market purchase is paid for by the insider, at the market price. 2020 to date brings 1 purchase and no sales.
Most recently, on 26 February 2020, the filings show an open-market purchase worth €8,945 in IRLAB Therapeutics AB. Filings reach the Finansinspektionen feed a median of 1 day after the trade. Under the Market Abuse Regulation, managers have three business days to notify their trades. This summary is built from Finansinspektionen disclosures alone and does not predict where the share price will go.
Companies and markets linked to Cecilia Tivert Stenberg
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 3,500 shares@ SEK 27.00100.0% of flowBTA (betald tecknad aktie)ISIN SE0013748332FI:csv-247c26a042e93b3109c0Canonical exit: 25 May 2020 (T+90)
- 31,299 shares@ SEK 92.18AktieISIN SE0012675379FI:csv-5ad1efceee2ef30a12d5
- 2,000 shares@ SEK 336.00AktieISIN SE0009242225FI:csv-37e00c60eac5e42db006
- 683 shares@ SEK 60.00ISIN SE0009242225FI:csv-68770d01f58b6cd17427
4 of 4 declarations